London · Delayed Price · Currency is GBP · Price in GBX ImmuPharma Statistics
Total Valuation
ImmuPharma has a market cap or net worth of GBP 20.04 million. The enterprise value is 19.34 million.
| Market Cap | 20.04M |
| Enterprise Value | 19.34M |
Important Dates
The next estimated earnings date is Friday, September 25, 2026.
| Earnings Date | Sep 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ImmuPharma has 625.29 million shares outstanding. The number of shares has increased by 18.35% in one year.
| Current Share Class | 625.29M |
| Shares Outstanding | 625.29M |
| Shares Change (YoY) | +18.35% |
| Shares Change (QoQ) | +11.57% |
| Owned by Insiders (%) | 0.60% |
| Owned by Institutions (%) | 70.44% |
| Float | 606.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 11.00 |
| P/TBV Ratio | 11.00 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.34
| Current Ratio | 1.34 |
| Quick Ratio | 0.78 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.81 |
Financial Efficiency
Return on equity (ROE) is -432.82% and return on invested capital (ROIC) is -137.35%.
| Return on Equity (ROE) | -432.82% |
| Return on Assets (ROA) | -63.37% |
| Return on Invested Capital (ROIC) | -137.35% |
| Return on Capital Employed (ROCE) | -130.18% |
| Weighted Average Cost of Capital (WACC) | 20.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -667,500 |
| Employee Count | 7 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -254,096 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -73.51% in the last 52 weeks. The beta is 3.00, so ImmuPharma's price volatility has been higher than the market average.
| Beta (5Y) | 3.00 |
| 52-Week Price Change | -73.51% |
| 50-Day Moving Average | 3.84 |
| 200-Day Moving Average | 5.08 |
| Relative Strength Index (RSI) | 43.96 |
| Average Volume (20 Days) | 1,822,519 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.37M |
| Pretax Income | -4.93M |
| Net Income | -4.67M |
| EBITDA | -2.42M |
| EBIT | -2.37M |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
The company has 695,836 in cash and no debt, with a net cash position of 695,836 or 0.00 per share.
| Cash & Cash Equivalents | 695,836 |
| Total Debt | n/a |
| Net Cash | 695,836 |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 1.82M |
| Book Value Per Share | 0.00 |
| Working Capital | 437,011 |
Cash Flow
In the last 12 months, operating cash flow was -1.85 million and capital expenditures -2,419, giving a free cash flow of -1.85 million.
| Operating Cash Flow | -1.85M |
| Capital Expenditures | -2,419 |
| Depreciation & Amortization | -50,845 |
| Net Borrowing | n/a |
| Free Cash Flow | -1.85M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ImmuPharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -18.35% |
| Shareholder Yield | -18.35% |
| Earnings Yield | -23.32% |
| FCF Yield | -9.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |